Subchronic effects of ochratoxin A on young adult rat brain and partial prevention by aspartame,a sweetener

Abstract

1. Ochratoxin A (OTA) is a mycotoxin produced by several fungi, especially Aspergillus and Penicillium species. Many food and foodstuffs can be contaminated by ochratoxin A, which is consequently found in blood of animals and humans.

2. The distribution into the brain of young adult rats fed OTA for 1 to 6 weeks and some consequences have been investigated in the present study.

3. Our results on rats given OTA (289 mg/kg/48 h) indicated that OTA accumulated in the whole brain as function of time according to a regression curve, Y=78.723 a+16.72 with a correlation coefficient of r=0.989, where Y-axis is the OTA concentration in ng/ g of brain and X-axis is the duration of the treatment in weeks. The brain OTA contents was 11.95+2.2, 23.89+4.4, 39.9+4.5, 50.3+7.3, 78.8+6.3, 94+16 ng/g of brain in the mycotoxin-treated animals for respectively 1, 2, 3, 4, 5 and 6-weeks treatment. OTA induced modifications of free amino-acid concentrations in the brain, mainly, Tyrosine (Tyr) and phenylalanine (Phe). Tyr decreased significantly as compared to control (p50.05). Phe increased signifi-cantly as compared to control (p<50.05).

4. Aspartame, (25 mg/kg/48 h) a structural analogue of OTA largely modified the distribution and prevented the accumulation of OTA in the brain since the respective brain OTA contents decreased respectively to 9.6+7.9, 19.2+3.0, 26.8+4.2, 19.7+1.9, 13.7+5.6 and 11.0+6.0 ng/g of tissue, for the same duration of treatment. It also prevented the modifications of Tyr and Phe levels.

5. The histological investigations showed several necrotic cells with pyknotic nucleus, detected in OTA treated animals with higher frequency as compared to the controls and Aspartame treated ones. Aspar-tame appeared to significantly prevent this nuclear effect as well, the meaning of which is discussed.

Keywords

ochratoxin A subchronic intoxication rat brain aspartame (ASP)phenylalanine tyrosine prevention

Get full access to this article

View all access options for this article.

References

Van der Merwe et al. Ochratoxin A, A toxic metabolite produced by Aspergillus ochraceus Wilh . Nature 1965; 205: 1112-1113 .

Krogh P. Ochratoxin in food. In: P. Krogh (ed), Mycotoxins in food. Academic Press: New York , 1987; 97-121.

Kuiper-Goodman T , Scoot PM. Risk assessment of the mycotoxin ochratoxin A . Biomed Environ Sci 1989 2: 179-248 .

INSERM . Human ochratoxicosis and its pathologies. Creppy EE , Castegnaro M , Dirheimer G. (eds), John Libbey Eurotext Ltd. 1993, vol. 231: pp 1-234.

Bunge I , Dirheimer G , Röschenthaler R. In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A . Biochem Byphys Res Comm 1978; 83: 398-405 .

Creppy EE et al. In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A . Chem Biol Interact 1979a; 24: 257-262 .

Omar RF , Rahimtula AD , Bartsch H. Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation . J Biochem Toxicol 1991; 6: 203-209 .

Galtier P , Alvinerie M , Charpenteau JL. The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens . Food Cosmet Toxicol 1981; 19: 735-738 .

Stojkovic R , Hult K , Gamulin S , Plestina R. High affinity of ochratoxin A to plasma constituents . Biochem Int 1984; 9: 33-38 .

10.

St'rmer FC. Ochratoxin A. A mycotoxin of concern. In: Handbook of applied mycology. Mycotoxins in Ecological Systems, Bhatnagar D , Lillehoj EB , Arora DK. (Eds) Marcel Dekker Inc. 1992; 5: 403-432.

11.

Creppy EE , Chakor K , Fisher MJ , Dirheimer G. The mycotoxin Ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo . Arch Toxicol 1990; 64: 279-284 .

12.

Ueno Y. Biotransformation of mycotoxins in the reconstituted cytochrome P-450 system . Proc Jpn Assoc Mycotoxicol 1985; 22: 28-30 .

13.

Kane A , Creppy EE , Röschenthaler R , Dirheimer G. Chanes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats . Toxicology 1986; 42: 233-243 .

14.

Petkova-Bocharova T , Chernozemsky IN , Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria . Food Addit Contam 1988; 5: 299-301 .

15.

Castegnaro M , Bartsch H , Chernozemsky IN. Endemic nephropathy and urinary tract tumours in the Balkans . Cancer Res 1987; 47: 3608-3609 .

16.

Gupta M , Bandyopaddhyay S , Paul B , Majumder SK. Haematological changes produced in mice by ochratoxin A . Toxicology 1979; 14: 95-98 .

17.

Pitout MJ. The effect of ochratoxin A on glycogen storage in rat liver . Toxicol Appl Pharmacol 1968; 13: 299-306 .

18.

Haubeck HD , Lorkowski G , Kolsch E , Röschenthaler R. Immunosuppression by ochratoxin A and its prevention by phenylalanine . Appl Environ Microbiol 1981; 41: 1040-1042 .

19.

Creppy EE , St'rmer FC , Röschenthaler R , Dirheimer G. Effects of two metabolites of ochratoxin A, [4R]-4-hydroxy ochratoxin A and ochratoxin A, on the immune response in mice . Infect Immun 1983; 39: 1015-1018 .

20.

St'rmer FC , Lea T , Effects of ochratoxin A upon early and late events in human T-cell proliferation . Toxicology 1995; 95: 45-50 .

21.

Arora RG , Frölen H. Interference of mycotoxins with prenatal development of the mouse. II. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestration . Acta Vet Scand 1981; 22: 535-552 .

22.

Mayura K , Parker R , Berndt WO , Phillips TD. Ochratoxin A induced teratogenesis in rats: partial protection by phenylalanine . Appl Environ Microbiol 1984; 48: 1186-1188 .

23.

Fukui Y , Hayasaka S , Itoh M , Takeuchi Y. Development of neurones and synapses in Ochratoxin A-induced microcephalic mice: a quantitative assessment of somatosensory cortex . Neurotoxicol and Teratol 1992; 14: 191-196 .

24.

Takanori M , Yoshihiro F , Nobuhisa U , Yoshiki T. Regional difference in the neurotoxicity of ochratoxin A on the developing cerebral cortex in mice . Developmental Brain Research 1994; 82: 259-264 .

25.

Creppy EE et al. Genotoxicity of Ochratoxin A in mice: DNA single-stand break evaluation in spleen, liver and kidney , Toxicol Lett 1985; 28: 29-35 .

26.

Pfohl-Leszkowicz A et al. Is the oxidative pathway implicated in the genotoxicity of ochratoxin A. In: EE Creppy , M Castegnaro , G Dirheimer (eds), Human ochratoxicosis and its pathologies, John Libbey EUROTEXT. vol 231, 1993, pp 177-188.

27.

NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A. (CAS No. 303-47-9) in F 344/N rats (gavage studies). Boorman G , (ed.) (NIH Publication No 89-2813) Research Triangle Park, NC, US Department of Health and Human Services , 1989.

28.

Tamaru M , Hirata Y , Matsutani T. Neurochemical effects of prenatal treatment with ochratoxin A on foetal and adult mouse brain . Neurochem Res 1988; 13: 1139-1147 .

29.

Creppy EE , Baudrimont I , Betbeder AM. Prevention of nephrotoxicity of ochratoxin A, a food contaminant . Toxicol Lett 1995; 82/83: 869-877 .

30.

Joseph MH , Marsden CA. HPLC of small molecules. In: CK Kim (ed.), A practical approach. IRL Press . 1986; 2: 13-28.

31.

Gad SC , Neil CS. Statistic for Toxicologists. In: Principles and methods of Toxicology 1982; 273-273.

32.

Madsen A , Mortensen HP , Hald B. Feeding experiments with ochratoxin contaminated barley for bacon pigs. Influence on pigs performance and residues . Acta Agric Scand 1982; 32-322 .

33.

Bauer J , Gareis M , Ochratoxin A in der Nahrungsmittelkette . ZVeterinärmed B 1987; 34: 613-627 .

34.

Creppy EE et al. Action of ochratoxin A on cultured hepatoma cells. Reversion of inhibition by phenylalanine . FEBS Lett 1976b, 2: 287-290 .

35.

Creppy EE et al. Inhibition of protein synthesis in mice by Ochratoxin A and its prevention by phenylalanine . Food Chem Toxicol 1984; 22: 883-886 .

36.

Klinkert W et al. Inhibition of macrophage migration by ochratoxin A and citrinin and prevention by phenylalanine of the ochratoxin A-induced inhibition . Toxicol Eur Res 1981; 3: 22-25 .

37.

Kane A , Creppy EE , Roth A , Röschenthaler R , Dirheimer G. Distribution of the [3H]-label from low doses of radioactive Ochratoxin A ingested by rats and evidence for DNA single-strand breaks caused in liver and kidneys . Arch Toxicol 1986; 58: 219-224 .

38.

Roth A et al. Evidence for an enterohepatic circulation of ochratoxin A in mice . Toxicology 1988; 48: 293-308 .

39.

Oppermann JA , Muldoon E , Ranney RE. Effect of aspartame on phenylalanine metabolism in the monkey . JNutr 1973; 103: 1460-1466 .

40.

Gupta V et al. Effect of Aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure . AMJClinNutr 1989; 49: 1302-1306 .

41.

Fukui Y et al. Placental transfer of Ochratoxin A and its cytotoxic effect on the mouse embryonic brain . Food Chem Toxicol 1987; 25: 17-24 .

42.

Matsutani T et al. A neurochemical study of developmental impairment of the brain caused by the administration of cytosine arabinoside during thefoetalorneonatalperiodofrats . Neurochem Res 1983; 8: 1295-1306 .

43.

Roak-Foltz R , Leveille GA. Projected aspartame intake: Daily ingestion of aspartic acid, phenylalanine and methanol. In: Aspartame: Physiology and Biochemistry ( Stegrink LD , Filer LJ, Jr. , (eds), Marcel Dekker: New York , Chap. 9, 1984.

44.

Szczech GM. Brain necrosis in mouse fetuses transplacentally exposed to the mycotoxin ochratoxin A . Toxicol and Appl Pharmacol 1981; 57: 127-137 .

45.

Godin M et al. Karyomegalic interstitial nephritis . Am J of Kidney Dis 1996; 27: 166-166 .